BackElekta AB Class B Overview

Elekta AB Class B Receivables

Track Elekta AB Class B's receivables ($7B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$6.99B
9.27% YoYΔ $-714.36M vs prior year quarter

Peer average

Loading

Elekta AB Class B Receivables History

Loading

Elekta AB Class B vs. peers: Receivables Comparison

Loading

Elekta AB Class B Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Elekta AB Class B (EKTAF) FAQ

As of the most recent data (April 2026), EKTAF shows a receivables of $7B. That compares with $7.7B in the prior-year period — down 9.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EKTAF's receivables is now $7B (was $7.7B) — a 9.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Elekta AB Class B is outperforming or lagging.

Tracking EKTAF's receivables over time shows whether Elekta AB Class B is scaling, shrinking, or reshaping that part of the business. The current reading is $7B That compares with $7.7B in the prior-year period — down 9.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Elekta AB Class B's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $7B) with ownership activity and broader fundamentals.

Elekta AB Class B's receivables is $7B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.